v3.26.1
Consolidated Statements of Stockholders' Equity and Mezzanine Equity - USD ($)
Total
KSOP Redeemable Common Stock Conversion
Redeemable Common Stock
Redeemable Common Stock
KSOP Redeemable Common Stock Conversion
Redeemable Common Stock
Total Mezzanine Equity
KSOP Redeemable Common Stock Conversion
Total ADS Stockholders’ Equity
Common Stock
Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Non-controlling Interest in Subsidiaries
Treasury Stock, Common
Beginning balance (in shares) at Mar. 31, 2023               79,057,000          
Beginning balance at Mar. 31, 2023 $ 841,640,000           $ 824,147,000 $ 11,647,000 $ 1,134,864,000 $ (27,580,000) $ 626,215,000 $ 17,493,000 $ (920,999,000)
Beginning Treasury stock, common, shares (in shares) at Mar. 31, 2023                         9,539,000
Mezzanine beginning balance (in shares) at Mar. 31, 2023         9,429,000                
Deferred Compensation - Unearned ESOP Shares, beginning balance at Mar. 31, 2023         $ (153,220,000)                
Mezzanine beginning balance at Mar. 31, 2023 153,220,000                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 513,291,000           509,915,000       509,915,000 3,376,000  
Other comprehensive gain (570,000)           (2,250,000)     (2,250,000)   1,680,000  
Common stock dividend (43,922,000)           (43,922,000)       (43,922,000)    
Dividend paid to noncontrolling interest holder (3,747,000)                     (3,747,000)  
Share repurchases (in shares)                         1,779,000
Share repurchases (210,715,000)           (210,715,000)           $ (210,715,000)
Mezzanine compensation (44,636,000)                        
KSOP Redeemable Common Stock Conversion, Mezzanine   $ (2,747,000)   $ (44,636,000)                  
KSOP redeemable common stock conversion (in shares)               2,747,000          
KSOP Redeemable Common Stock Conversion 44,636,000           44,636,000 $ 27,000 44,609,000        
Exercise of common stock options (in shares)               159,000          
Exercise of common stock options 6,454,000           6,454,000 $ 2,000 6,452,000        
Restricted stock awards (in shares)               100,000         25,000
Restricted stock awards (2,467,000)           (2,467,000) $ 1,000         $ (2,468,000)
Performance-based restricted stock units (in shares)               200,000         72,000
Performance-based restricted stock units (6,394,000)           (6,394,000) $ 2,000         $ (6,396,000)
Stock-based compensation 31,986,000           31,986,000   31,986,000        
ESPP Issuance (in shares)               20,000          
ESPP Issuance 1,927,000           1,927,000   1,927,000        
Other (4,000)           (4,000)   (4,000)        
Ending balance (in shares) at Mar. 31, 2024               82,283,000          
Ending balance at Mar. 31, 2024 1,172,115,000           1,153,313,000 $ 11,679,000 1,219,834,000 (29,830,000) 1,092,208,000 18,802,000 $ (1,140,578,000)
Ending Treasury stock, common, shares (in shares) at Mar. 31, 2024                         11,415,000
Deferred Compensation - Unearned ESOP Shares, ending balance at Mar. 31, 2024         $ (108,584,000)                
Mezzanine ending balance (in shares) at Mar. 31, 2024         6,682,000                
Mezzanine ending balance at Mar. 31, 2024 108,584,000                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 452,573,000           450,172,000       450,172,000 2,401,000  
Other comprehensive gain (10,851,000)           (7,348,000)     (7,348,000)   (3,503,000)  
Common stock dividend $ (49,746,000)           (49,746,000)       (49,746,000)    
Share repurchases (in shares) 400,000                       410,000
Share repurchases $ (68,172,000)           (68,172,000)           $ (68,172,000)
Mezzanine compensation (15,932,000)   $ (15,932,000)                    
Compensation (in shares)     (980,000)                    
ESOP Compensation 15,932,000           15,932,000   15,922,000        
KSOP redeemable common stock conversion (in shares)               980,000          
KSOP Redeemable Common Stock Conversion               $ 10,000          
Exercise of common stock options (in shares)               244,000          
Exercise of common stock options 9,971,000           9,971,000 $ 2,000 9,969,000        
Restricted stock awards (in shares)               100,000         27,000
Restricted stock awards (4,719,000)           (4,719,000) $ 1,000         $ (4,720,000)
Performance-based restricted stock units (in shares)               93,000         34,000
Performance-based restricted stock units (5,937,000)           (5,937,000) $ 1,000         $ (5,938,000)
Stock-based compensation 26,581,000           26,581,000   26,581,000        
ESPP Issuance               $ 1,000          
ESPP Issuance (in shares)               50,000          
ESPP Issuance 5,392,000           5,392,000   5,391,000        
Other (3,000)           (3,000)   (3,000)        
Ending balance (in shares) at Mar. 31, 2025               83,750,000          
Ending balance at Mar. 31, 2025 1,543,136,000           1,525,436,000 $ 11,694,000 1,277,694,000 (37,178,000) 1,492,634,000 17,700,000 $ (1,219,408,000)
Ending Treasury stock, common, shares (in shares) at Mar. 31, 2025                         11,886,000
Redeemable Convertible Preferred Stock, ending balance at Mar. 31, 2025     $ 92,652,000                    
Mezzanine ending balance (in shares) at Mar. 31, 2025     5,702,000                    
Mezzanine ending balance at Mar. 31, 2025 92,652,000                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 428,773,000           426,465,000       426,465,000 2,308,000  
Other comprehensive gain 7,076,000           4,888,000     4,888,000   2,188,000  
Common stock dividend (56,163,000)           (56,163,000)       (56,163,000)    
Dividend paid to noncontrolling interest holder $ (1,960,000)                     (1,960,000)  
Share repurchases (in shares) 700,000                       720,000
Share repurchases $ (99,245,000)           (99,245,000)           $ (99,245,000)
KSOP share conversion (in shares)       (1,169,000)                  
KSOP Redeemable Common Stock Conversion, Mezzanine       $ (19,000,000)   $ (19,000,000)              
KSOP redeemable common stock conversion (in shares)               1,169,000          
KSOP Redeemable Common Stock Conversion 19,000,000           19,000,000 $ 12,000 18,988,000        
Exercise of common stock options (in shares)               152,000          
Exercise of common stock options 6,850,000           6,850,000 $ 1,000 6,849,000        
Contribution from noncontrolling interest holder 3,342,000                     3,342,000  
Restricted stock awards (in shares)               100,000         30,000
Restricted stock awards (3,483,000)           (3,483,000) $ 1,000         $ (3,484,000)
Performance-based restricted stock units (in shares)               85,000         29,000
Performance-based restricted stock units (3,575,000)           (3,575,000) $ 1,000         $ (3,576,000)
Stock-based compensation 32,354,000           32,354,000   32,354,000        
ESPP Issuance               $ 1,000          
ESPP Issuance (in shares)               63,000          
ESPP Issuance 6,208,000           6,208,000   6,207,000        
Other (1,000)           (1,000)   (1,000)        
Ending balance (in shares) at Mar. 31, 2026               85,319,000          
Ending balance at Mar. 31, 2026 1,882,312,000           $ 1,858,734,000 $ 11,710,000 $ 1,342,091,000 $ (32,290,000) $ 1,862,936,000 $ 23,578,000 $ (1,325,713,000)
Ending Treasury stock, common, shares (in shares) at Mar. 31, 2026                         12,665,000
Redeemable Convertible Preferred Stock, ending balance at Mar. 31, 2026     $ 73,652,000                    
Mezzanine ending balance (in shares) at Mar. 31, 2026     4,533,000                    
Mezzanine ending balance at Mar. 31, 2026 $ 73,652,000